Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
about
Natural killer cells in hepatitis C: Current progressHepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.Immunity to viruses.Extracellular HCV-core protein induces an immature regulatory phenotype in NK cells: implications for outcome of acute infectionHepatitis C virus impairs natural killer cell activity via viral serine protease NS3.Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis.Protective immunity against hepatitis C: many shades of gray.Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.Immune control and failure in HCV infection--tipping the balance.Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during TherapyCD4+ and CD8+ T Cell Activation in Children with Hepatitis C.Immunological changes in different patient populations with chronic hepatitis C virus infection.Accumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV InfectionAn insight into the diagnosis and pathogenesis of hepatitis C virus infection.Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis.Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma.OP9 Feeder Cells Are Superior to M2-10B4 Cells for the Generation of Mature and Functional Natural Killer Cells from Umbilical Cord Hematopoietic Progenitors.Host-virus interactions in hepatitis B and hepatitis C infection.Organ system view of the hepatic innate immunity in HCV infection.Immune regulation in chronic hepatitis C virus infection.NK cells in self-limited HCV infection exhibit a more extensively differentiated, but not memory-like, repertoire.CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.Altered natural killer cells subsets distribution in children with hepatitis C following vertical transmission.Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B.Innate and Adaptive Immune Responses in Chronic HCV Infection.Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells.Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2.Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage.Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment.Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
P2860
Q26773264-C4E96C37-D004-4938-B9F2-8DBE154E1733Q30277650-EF78C20B-2BB4-4AE6-BB73-0CF042D30B4CQ30411004-69B8C4FB-4FD3-4688-B348-036C33B95789Q30411437-0C5D3622-EAE9-4031-821F-087BD3FB7832Q33565605-1D2A781D-CC38-472B-9C17-3514F12BC1FBQ33745372-709FF741-4769-4DED-87BC-AB1AFC0CCE5FQ33759224-6211D620-8FC1-4F12-A15C-3147BA9841CAQ34078846-FE5E1044-EEC1-4397-8E6F-78D4B29BF30DQ34178628-E948BE3E-F05F-4973-8CEA-D55766C646D9Q36077824-74237B29-5C62-4DA0-9A31-D5B04C0897F4Q36803044-99CF7277-A51E-4ACC-B00E-E34F515BD050Q36919439-178EB4C2-79D8-4312-B5E7-04FECBE22824Q36993610-B3FE018C-8194-4DB9-B778-BAF940D89EF8Q38168827-F4E4F313-8C10-480B-A1BA-20FD0044CE4EQ38540088-513D04CE-C8A6-4712-BD09-A286C95FFEFAQ38635000-B2F8E7A0-2E6E-4F86-99CB-48E1D44BFFDAQ38656761-FB197960-342D-4F20-9E75-140480E4D379Q38740771-9CD1A099-112F-4893-A5A0-80E5B7958121Q38827613-D0B4AE80-F3AE-4D77-B164-00033E2B3995Q38902559-FA8F406F-0A13-4733-A754-FBDCA19B6342Q40240181-6DD8BBA5-CADD-429A-8473-B94722AAACFFQ40246889-9CC816E7-469E-4185-8074-F2E97434FB08Q40414240-70AB6E13-755A-4972-A1D0-A19411494E52Q40809341-73970209-4813-42E4-ABF0-32A1D33089D7Q40950668-FEE3F3FD-8D46-41A5-A352-4E97904C392BQ40956888-9D3557C9-F21E-4760-90CB-9C3FE0BDDB07Q41035955-E98A32B8-A367-4252-A05C-255DF0D486EEQ41082823-E7346842-6501-479D-9713-FE19827C4ADDQ41756934-40C03407-57F1-47CD-ACD4-22F14A7EB01DQ47117842-20C25CAB-4779-45C6-A9EF-C298FC96923CQ48374329-FDD44471-4BA0-460D-A3E3-AB603ECDA8D8Q52605839-51BC7589-5C69-48F0-92CE-DDCDC58C80D7Q52779233-9C98F105-B974-4D4A-BBEF-F52914D97DF4Q58755253-26105B23-027A-41C2-A10D-A2B427F91788
P2860
Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
@en
Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
@nl
type
label
Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
@en
Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
@nl
prefLabel
Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
@en
Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
@nl
P2860
P356
P1476
Natural killer cells: multifaceted players with key roles in hepatitis C immunity.
@en
P2093
Hugo R Rosen
Lucy Golden-Mason
P2860
P356
10.1111/IMR.12090
P577
2013-09-01T00:00:00Z